On Jan 24, 2022 BenchSci closed a Series C round and raised CA$63,000,000 from Inovia Capital, TCV, featuring lead investors Inovia Capital, TCV.

About the company: BenchSci is located at Canada, North America.
“BenchSci is the world leader in AI-Assisted Reagent Selection and Experiment Design. Our preclinical R&D SaaS platform uses machine learning to help pharmaceutical companies increase their research velocity.
”

Company website: http://www.benchsci.com